tiprankstipranks
Trending News
More News >
AbCellera Biologics (ABCL)
NASDAQ:ABCL

AbCellera Biologics (ABCL) Revenue

Compare
2,296 Followers

AbCellera Biologics Revenue

AbCellera Biologics had a revenue of 44.85M in the quarter ending Dec 31, 2025, with 400.88%. This bring the company's revenue in the last twelve months to 75.13M, Decreased 112.68%. In the fiscal year ending Dec 31, 2025, AbCellera Biologics had annual revenue of 75.13M with 160.56% growth.
Revenue (ttm)
75.13M
Revenue Growth
7.16%
P/S Ratio
13.92
Revenue/Employee
$126,054
Employees
596
Market Cap
$1.05B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
75.13M46.30M+160.56%
Dec 31, 2024
28.83M-9.19M-24.17%
Dec 31, 2023
38.02M-447.40M-92.17%
Dec 31, 2022
485.42M110.22M+29.38%
Dec 31, 2021
375.20M142.05M+60.92%
Dec 31, 2020
233.16M221.54M+1,907.88%
Dec 31, 2019
11.61M2.78M+31.49%
Dec 31, 2018
8.83M